0 items USD 0.00Search
Your search for "gbi research nsclc therapeutics asia pacific markets 2019 personalized therapies focus untapped" gave back 83405 results.
Highlights The global Lung Cancer Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The “Lung Cancer Therapeutics Industry Forecast” looks at past sales and reviews total world Lung Cancer Therapeutics sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global RNA Interference Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
February 2024
Price: USD 3,480.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can...
Catalog:
GIR
February 2023
Price: USD 3,480.00
